December 1, 2025

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook with a 14.76% Potential Upside

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, continues to draw investor interest with its robust performance metrics and promising pipeline. With a market capitalization of $15.17..

HealthEquity (HQY) Stock Analysis: Exploring a Promising 14.41% Upside in the Burgeoning Healthcare Sector

HealthEquity, Inc. (NASDAQ: HQY) stands prominently in the healthcare sector, specializing in health information services. The company provides a range of technology-enabled platforms that facilitate health savings accounts, flexible spending..

Legend Biotech Corporation (LEGN) Stock Analysis: Unlocking a 170% Potential Upside with Cutting-Edge CAR-T Therapies

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, is drawing significant attention from investors with its potential for a remarkable 170% upside. With a current market..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Robust Growth Trajectory in Healthcare

Medpace Holdings, Inc. (NASDAQ: MEDP), a stalwart in the healthcare sector, specifically within the diagnostics and research industry, is marking its presence on the stock market with a notable market..

Globus Medical, Inc. (GMED) Stock Analysis: Riding the Wave of 22.9% Revenue Growth in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, specializes in cutting-edge medical devices targeting musculoskeletal disorders. With a market capitalization of $12.3 billion, this Audubon, Pennsylvania-based..

Roivant Sciences Ltd. (ROIV) Stock Report: Analyzing a 17.95% Potential Upside for Biotech Investors

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, has drawn significant attention from investors eyeing the healthcare industry. Based in London, this clinical-stage biopharmaceutical company is..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth in the Global Animal Health Market

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, specifically in the drug manufacturing industry, is making strides in the global animal health market. With a..

Insmed Incorporated (INSM) Stock Analysis: Exploring Growth Potential in Biotechnology with a 52.4% Revenue Surge

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is drawing significant attention from investors, fueled by its robust revenue growth and promising drug pipeline. With a market..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Giant with an 8% Upside Potential

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, operates within the diagnostics and research industry, boasting a market capitalization of $39.17 billion. With its headquarters in Durham,..

McKesson Corporation (MCK) Stock Analysis: Navigating Opportunities in Healthcare with a 6.09% Potential Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, stands as a key player in the medical distribution industry with a robust market capitalization of $109.6 billion. With a..

Doximity, Inc. (DOCS): Investor Outlook with a 33% Upside Potential and Strong Market Position

Doximity, Inc. (DOCS), a prominent player in the healthcare sector, operates as a digital platform tailored for medical professionals in the United States. With a market capitalization of $9.68 billion,..

Exelixis, Inc. (EXEL) Stock Analysis: Strong Buy Ratings and Promising Growth in Oncology

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology sector with its keen focus on developing innovative oncology treatments. As a key player in the healthcare industry, Exelixis has carved..

Fresenius Medical Care AG (FMS) Stock Analysis: Exploring a 23% Upside Potential Amidst Healthcare Sector Dynamics

Fresenius Medical Care AG (NYSE: FMS), a leading player in the healthcare sector specializing in renal care services, offers a compelling investment case for those focused on long-term growth opportunities...

Bio-Rad Laboratories, Inc. (BIO): Investor Outlook on Potential Upside and Market Position

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a significant player within the healthcare sector, specifically in the medical devices industry. With a robust market capitalization of $8.76 billion, the company..

Waystar Holding Corp. (WAY) Stock Analysis: Navigating a 33% Potential Upside in the Healthcare Information Sector

Waystar Holding Corp. (WAY), a key player in the Healthcare Information Services industry, is capturing investor interest with a compelling potential upside of 33.18%. With a market cap of $7.06..

Royalty Pharma plc (RPRX) Stock Analysis: Discovering the 14.90% Potential Upside for Investors

Royalty Pharma plc (NASDAQ: RPRX) stands at the intersection of innovation and investment in the biotechnology sector, offering a unique opportunity for investors interested in the healthcare industry. With a..

Novartis AG (NVS) Investor Outlook: Navigating a Healthcare Giant with a 32.62% ROE

As a cornerstone of the healthcare sector, Novartis AG (NYSE: NVS) stands as a formidable player in the pharmaceutical industry. With a market capitalization of $250.21 billion, this Swiss-based juggernaut..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with 17.55% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector with its promising pipeline of transformative medicines targeting genetic diseases and cancers. With a market cap of $13.88..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 7.22% Potential Upside Amidst Market Volatility

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, stands out in the healthcare industry with a market capitalization of $10.05 billion. Headquartered in Minneapolis, Minnesota, the company..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 28.42% Potential Upside

Baxter International Inc. (NYSE: BAX) offers a compelling case study for investors interested in the healthcare sector, particularly those focused on medical instruments and supplies. With a market capitalization of..

Search

Funds

December 1, 2025

Search

Funds

December 1, 2025

FTSE 100

Funds